Ionis-backed Dynacure bags €47M to start clinical trials

Ionis-backed Dynacure bags €47M to start clinical trials

Source: 
Fierce Biotech
snippet: 

Dynacure has raised €47 million ($55 million) to take an antisense oligonucleotide therapy into the clinic. The French biotech picked up the centronuclear myopathy (CNM) prospect from its cofounder, Ionis Pharmaceuticals.